Hoffmann-Vold, A., Tennøe, A. H., Garen, T., Midtvedt, Ø., Abraityte, A., Aaløkken, T. M., . . . Molberg, Ø. (2016). High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis. Chest, 150(2), 299. https://doi.org/10.1016/j.chest.2016.03.004
Chicago Style (17th ed.) CitationHoffmann-Vold, Anna-Maria, et al. "High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis." Chest 150, no. 2 (2016): 299. https://doi.org/10.1016/j.chest.2016.03.004.
MLA (9th ed.) CitationHoffmann-Vold, Anna-Maria, et al. "High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis." Chest, vol. 150, no. 2, 2016, p. 299, https://doi.org/10.1016/j.chest.2016.03.004.